Advertisement
Screener

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Increase (Decrease) in Due to Officers and Stockholders

2.8 / 5 stars · 68/120 Roast Me

IOVANCE BIOTHERAPEUTICS, INC. Increase (Decrease) in Due to Officers and Stockholders

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Increase (Decrease) in Due to Officers and Stockholders of $18.14 thousand for the 78-month period ending 2014-03-31, per its 10-Q filed 2014-05-14.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInDueToOfficersAndStockholders · last filed 2014-05-14

  • IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in due to officers and stockholders for the quarter ending 2013-12-31 was $0.00.
  • IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in due to officers and stockholders for the quarter ending 2013-09-30 was $0.00.
  • IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in due to officers and stockholders for the quarter ending 2013-06-30 was $0.00.
  • IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in due to officers and stockholders for the quarter ending 2013-03-31 was $0.00.
  • IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in due to officers and stockholders for fiscal 2013 was $0.00.
  • IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in due to officers and stockholders for fiscal 2012 was $0.00.
  • IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in due to officers and stockholders for fiscal 2011 was $0.00.
  • IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in due to officers and stockholders for fiscal 2010 was -$4.98K, a 125.17% decline from fiscal 2009.
Period endIncrease (Decrease) in Due to Officers and Stockholders 3 monthIncrease (Decrease) in Due to Officers and Stockholders 6 monthIncrease (Decrease) in Due to Officers and Stockholders 9 monthIncrease (Decrease) in Due to Officers and Stockholders 12 monthIncrease (Decrease) in Due to Officers and Stockholders 45 monthIncrease (Decrease) in Due to Officers and Stockholders 48 monthIncrease (Decrease) in Due to Officers and Stockholders 51 monthIncrease (Decrease) in Due to Officers and Stockholders 54 monthIncrease (Decrease) in Due to Officers and Stockholders 57 monthIncrease (Decrease) in Due to Officers and Stockholders 60 monthIncrease (Decrease) in Due to Officers and Stockholders 63 monthIncrease (Decrease) in Due to Officers and Stockholders 66 monthIncrease (Decrease) in Due to Officers and Stockholders 69 monthIncrease (Decrease) in Due to Officers and Stockholders 72 monthIncrease (Decrease) in Due to Officers and Stockholders 78 month
2014-03-31$18.14K
10-Q · filed 2014-05-14
2013-12-31$0.00
derived: 10-K 12 month − 3 quarters · filed 2014-03-28
$0.00
derived: sum of 2 quarters · filed 2014-03-28
$0.00
derived: sum of 3 quarters · filed 2014-03-28
$0.00
10-K · filed 2014-03-28
$18.14K
10-K · filed 2014-03-28
2013-09-30$0.00
derived: 10-Q 72 month − 10-Q 69 month · filed 2013-11-14
$0.00
derived: sum of 2 quarters · filed 2013-11-14
$0.00
derived: sum of 3 quarters · filed 2013-11-14
$0.00
derived: sum of 4 quarters · filed 2014-03-28
$18.14K
10-Q · filed 2013-11-14
2013-06-30$0.00
derived: 10-Q 69 month − 10-Q 66 month · filed 2013-10-23
$0.00
derived: sum of 2 quarters · filed 2013-10-23
$0.00
derived: sum of 3 quarters · filed 2014-03-28
$0.00
derived: sum of 4 quarters · filed 2014-03-28
$18.14K
10-Q · filed 2013-10-23
2013-03-31$0.00
10-Q · filed 2013-10-23
$0.00
derived: sum of 2 quarters · filed 2014-03-28
$0.00
derived: sum of 3 quarters · filed 2014-03-28
$0.00
derived: sum of 4 quarters · filed 2014-03-28
$18.14K
10-Q · filed 2013-10-23
2012-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28
$0.00
derived: sum of 2 quarters · filed 2014-03-28
$0.00
derived: sum of 3 quarters · filed 2014-03-28
$0.00
10-K · filed 2014-03-28
$18.14K
10-K · filed 2013-09-23
2012-09-30$0.00
derived: 10-Q 60 month − 10-Q/A 57 month · filed 2013-01-25
$0.00
derived: sum of 2 quarters · filed 2013-01-25
$0.00
10-Q · filed 2013-01-25
$0.00
derived: sum of 4 quarters · filed 2013-10-23
$18.14K
10-Q · filed 2013-01-25
2012-06-30$0.00
derived: 10-Q/A 57 month − 10-Q 54 month · filed 2012-09-10
$0.00
derived: sum of 2 quarters · filed 2013-10-23
$0.00
derived: sum of 3 quarters · filed 2013-10-23
$0.00
derived: sum of 4 quarters · filed 2013-10-23
$18.14K
10-Q/A · filed 2012-09-10
2012-03-31$0.00
10-Q · filed 2013-10-23
$0.00
derived: sum of 2 quarters · filed 2013-10-23
$0.00
derived: sum of 3 quarters · filed 2013-10-23
$0.00
derived: sum of 4 quarters · filed 2013-10-23
$18.14K
10-Q · filed 2012-05-15
2011-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30
$0.00
derived: sum of 2 quarters · filed 2013-01-25
$0.00
derived: sum of 3 quarters · filed 2013-01-25
$0.00
10-K · filed 2012-03-30
$18.14K
10-K · filed 2012-03-30
2011-09-30$0.00
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-01-25
$0.00
derived: sum of 2 quarters · filed 2013-01-25
$0.00
10-Q · filed 2013-01-25
$18.14K
derived: sum of 4 quarters · filed 2013-01-25
$18.14K
10-Q · filed 2011-11-21
2011-06-30$0.00
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2011-09-01
$0.00
10-Q/A · filed 2011-09-01
$18.14K
derived: sum of 3 quarters · filed 2012-05-15
$18.14K
derived: sum of 4 quarters · filed 2012-05-15
$18.14K
10-Q/A · filed 2011-09-01
2011-03-31$0.00
10-Q · filed 2012-05-15
$18.14K
derived: sum of 2 quarters · filed 2012-05-15
$18.14K
derived: sum of 3 quarters · filed 2012-05-15
2010-12-31$18.14K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30
$18.14K
derived: sum of 2 quarters · filed 2012-03-30
-$4.98K
10-K · filed 2012-03-30
2010-09-30$0.00
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21
-$23.12K
10-Q · filed 2011-11-21
2010-06-30-$23.12K
10-Q/A · filed 2011-09-01
2009-12-31$19.80K
10-K · filed 2012-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Adaptive Biotechnologies Corp (ADPT)United States$4.719B-53.43
CRISPR Therapeutics AG (CRSP)$5.390B-11.68
Relay Therapeutics, Inc. (RLAY)United States$3.884B-14.30
Scholar Rock Holding Corp (SRRK)United States$5.920B-16.37
CG Oncology, Inc. (CGON)United States$6.095B-27.95
Tarsus Pharmaceuticals, Inc. (TARS)United States$3.329B-58.60
Denali Therapeutics Inc. (DNLI)United States$3.274B-8.04
Immunovant, Inc. (IMVT)United States$7.028B-14.78
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
Greenland Mines Ltd (GRML)United States$2.362B